Software as a Medical Service, or SaMS, Takes Spotlight in New CMS Proposal
Clinical labs have until Aug. 31 to submit public comments about the anticipated changes
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Clinical labs have until Aug. 31 to submit public comments about the anticipated changes
Acquisition likely isn’t a full-blown push into Native American healthcare, consultant Larry Worden says
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
These core steps are fundamental for protecting laboratory workers from airborne contamination
The proposal seeks to move any future LDT authority away from the FDA
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Deal could prove a boost to the company, which has struggled since 2023
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Hologic has been on the vanguard of developing and distributing tests focusing on women’s health